MeSH term
Frequency | Condition_Probility | Animals | 14 | 0.0 |
*Dosage Compensation (Genetics) | 11 | 6.0 |
Humans | 8 | 0.0 |
*RNA, Untranslated | 13 | 6.0 |
Research Support, Non-U.S. Gov't | 13 | 0.0 |
Transcription Factors/genetics | 3 | 0.0 |
X Chromosome/*genetics | 4 | 1.0 |
Dosage Compensation (Genetics) | 2 | 1.0 |
Female | 11 | 0.0 |
Karyotyping | 2 | 0.0 |
Phosphoglycerate Kinase/genetics | 2 | 5.0 |
Polymerase Chain Reaction | 4 | 0.0 |
Cell Line | 4 | 0.0 |
Chromosomes, Artificial, Yeast | 2 | 0.0 |
CpG Islands | 2 | 0.0 |
In Situ Hybridization, Fluorescence | 6 | 0.0 |
Male | 11 | 0.0 |
Mice | 11 | 0.0 |
Transcription Factors/*genetics | 9 | 0.0 |
Transcription, Genetic | 3 | 0.0 |
Transgenes | 2 | 0.0 |
*X Chromosome | 6 | 0.0 |
Chimera | 2 | 1.0 |
Gene Expression | 2 | 0.0 |
Mice, Inbred C57BL | 3 | 0.0 |
Mice, Transgenic | 4 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 6 | 0.0 |
Transfection | 2 | 0.0 |
Acetylation | 2 | 0.0 |
Chromosome Mapping | 4 | 0.0 |
DNA-Binding Proteins/genetics | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 2 | 0.0 |
RNA/metabolism | 4 | 0.0 |
Base Sequence | 5 | 0.0 |
Lac Operon | 2 | 1.0 |
Molecular Sequence Data | 5 | 0.0 |
DNA Primers | 2 | 0.0 |
Gene Expression Regulation, Developmental | 2 | 0.0 |
Homeodomain Proteins/genetics | 2 | 0.0 |
